-
Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market Gallery
Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market
-
Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery
Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)
-
Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant Expanded Access Program For Pitolisant Is Open And Patients Are Being Enrolled Gallery
Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant Expanded Access Program For Pitolisant Is Open And Patients Are Being Enrolled